Series B - Harpoon Therapeutics
Investment Firm
Overview
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Announced Date
May 25, 2017
Closed on Date
May 25, 2017
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
MPM Capital
MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.
New Leaf Venture Partners
New Leaf Venture Partners is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.
Arix Bioscience
Arix Bioscience is a early_stage_venture and late_stage_venture and seed firm.
Participant Investors
5
Round Details and Background
Harpoon Therapeutics raised $45000000 on 2017-05-25 in Series B
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 23, 2023 |  Post-IPO Equity - Harpoon Therapeutics | 10 | - | 100.0M |
| Mar 27, 2023 | Post-IPO Equity - Harpoon Therapeutics | 5 | - | 25.0M |
| May 25, 2017 | Series B - Harpoon Therapeutics | 5 | - | 45.0M |
| Apr 01, 2016 | Series A - Harpoon Therapeutics | 2 | - | 15.0M |
Recent Activity
There is no recent news or activity for this profile.